Sign in
4

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-19-018088

Options or other derivatives

  • SVP and Chief Business Officer acquired 165,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Mancilla Bethany SVP and Chief Business Officer 2019-03-06 Grant or award · Stock Option (right to buy) +65,000 65,000 D
Mancilla Bethany SVP and Chief Business Officer 2019-03-06 Grant or award · Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X03/doc4.xml…